Jump to main content
Jump to site search

Issue 3, 2016
Previous Article Next Article

Development of a competitive binding assay for the Burkholderia cenocepacia lectin BC2L-A and structure activity relationship of natural and synthetic inhibitors

Author affiliations

Abstract

Burkholderia cenocepacia is an opportunistic Gram-negative pathogen and especially hazardous for cystic fibrosis patients. In analogy to its relative Pseudomonas aeruginosa, B. cenocepacia possess numerous lectins with roles in adhesion and biofilm formation. The LecB homolog BC2L-A is important for biofilm structure and morphology. Inhibitors of this D-mannose specific C-type lectin could be useful as tools in B. cenocepacia biofilm research and potentially as anti-biofilm compounds against chronic infections. Here, we report the development of a fluorescence polarization-based competitive binding assay and its application in an extensive structure–activity relationship study of inhibitors of BC2L-A. In contrast to its homolog LecB, BC2L-A is highly selective for D-mannose-based ligands with an absolute requirement of its hydroxyl group at C6. A strict diastereoselectivity was observed for (6S)-mannoheptose-derived ligands. Intriguingly, bioisosteric substitution or methylation of hydroxyl groups directly involved in the calcium-coordination resulted in loss of inhibition for the two homologous lectins BC2L-A and LecB.

Graphical abstract: Development of a competitive binding assay for the Burkholderia cenocepacia lectin BC2L-A and structure activity relationship of natural and synthetic inhibitors

Back to tab navigation

Supplementary files

Publication details

The article was received on 04 Dec 2015, accepted on 12 Jan 2016 and first published on 13 Jan 2016


Article type: Research Article
DOI: 10.1039/C5MD00557D
Author version
available:
Download author version (PDF)
Citation: Med. Chem. Commun., 2016,7, 519-530
  •   Request permissions

    Development of a competitive binding assay for the Burkholderia cenocepacia lectin BC2L-A and structure activity relationship of natural and synthetic inhibitors

    G. Beshr, R. Sommer, D. Hauck, D. C. B. Siebert, A. Hofmann, A. Imberty and A. Titz, Med. Chem. Commun., 2016, 7, 519
    DOI: 10.1039/C5MD00557D

Search articles by author

Spotlight

Advertisements